Does OCRELIZUMAB Cause Maternal exposure before pregnancy? 434 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 434 reports of Maternal exposure before pregnancy have been filed in association with OCRELIZUMAB (OCREVUS). This represents 0.8% of all adverse event reports for OCRELIZUMAB.
434
Reports of Maternal exposure before pregnancy with OCRELIZUMAB
0.8%
of all OCRELIZUMAB reports
2
Deaths
72
Hospitalizations
How Dangerous Is Maternal exposure before pregnancy From OCRELIZUMAB?
Of the 434 reports, 2 (0.5%) resulted in death, 72 (16.6%) required hospitalization, and 5 (1.2%) were considered life-threatening.
Is Maternal exposure before pregnancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OCRELIZUMAB. However, 434 reports have been filed with the FAERS database.
What Other Side Effects Does OCRELIZUMAB Cause?
Covid-19 (11,454)
Fatigue (5,704)
Urinary tract infection (3,618)
Headache (3,036)
Multiple sclerosis (2,609)
Asthenia (2,509)
Nasopharyngitis (2,479)
Gait disturbance (2,384)
Pneumonia (2,333)
Pain (2,327)
What Other Drugs Cause Maternal exposure before pregnancy?
CERTOLIZUMAB PEGOL (1,680)
LEVONORGESTREL (557)
METHOTREXATE (267)
ETHINYL ESTRADIOL\ETONOGESTREL (257)
LEVETIRACETAM (256)
CYCLOPHOSPHAMIDE (221)
FINGOLIMOD (180)
LACOSAMIDE (154)
RITUXIMAB (133)
ISOTRETINOIN (112)
Which OCRELIZUMAB Alternatives Have Lower Maternal exposure before pregnancy Risk?
OCRELIZUMAB vs OCRIPLASMIN
OCRELIZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OCRELIZUMAB vs OCTINOXATE\OCTOCRYLENE
OCRELIZUMAB vs OCTREOTIDE
OCRELIZUMAB vs OCTREOTIDE\OCTREOTIDE